BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 34433351)

  • 1. Nomograms for Individualized Evaluation of Prognosis in Adrenocortical Carcinomas for the Elderly: A Population-Based Analysis.
    Wang W; Chang G; Sun Y; Zhuo R; Li H; Hu Y; Ye C
    J Invest Surg; 2022 May; 35(5):1153-1160. PubMed ID: 34433351
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nomograms to Predict Recurrence-Free and Overall Survival After Curative Resection of Adrenocortical Carcinoma.
    Kim Y; Margonis GA; Prescott JD; Tran TB; Postlewait LM; Maithel SK; Wang TS; Evans DB; Hatzaras I; Shenoy R; Phay JE; Keplinger K; Fields RC; Jin LX; Weber SM; Salem AI; Sicklick JK; Gad S; Yopp AC; Mansour JC; Duh QY; Seiser N; Solorzano CC; Kiernan CM; Votanopoulos KI; Levine EA; Poultsides GA; Pawlik TM
    JAMA Surg; 2016 Apr; 151(4):365-73. PubMed ID: 26676603
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A nomogram for individualized estimation of survival among adult patients with adrenocortical carcinoma after surgery: a retrospective analysis and multicenter validation study.
    Kong J; Zheng J; Cai J; Wu S; Diao X; Xie W; Chen X; Liao C; Yu H; Fan X; Huang C; Liu Z; Chen W; Lv Q; Qin H; Huang J; Lin T
    Cancer Commun (Lond); 2019 Nov; 39(1):80. PubMed ID: 31775884
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The clinical utility of 'GRAS' parameters in stage I-III adrenocortical carcinomas: long-term data from a high-volume institution.
    Liang J; Liu Z; Zhou L; Tang Y; Zhou C; Wu K; Zhang F; Zhang F; Wei X; Lu Y; Zhu Y
    Endocrine; 2020 Feb; 67(2):449-456. PubMed ID: 31786772
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Contrast CT radiomic features add value to prediction of prognosis in adrenal cortical carcinoma.
    Liu J; Lin W; Yan L; Xie J; Dai J; Xu D; Zhao J
    Endocrine; 2024 Mar; 83(3):763-774. PubMed ID: 37968537
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development and validation of prognostic nomograms in patients with adrenocortical carcinoma: a population-based study.
    Zhang H; Naji Y; Yan M; Lian W; Xie M; Dai Y
    Int Urol Nephrol; 2020 Jun; 52(6):1057-1071. PubMed ID: 32072388
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nomograms to predict overall survival and cancer-specific survival in patients with adrenocortical carcinoma.
    Li Y; Bian X; Ouyang J; Wei S; He M; Luo Z
    Cancer Manag Res; 2018; 10():6949-6959. PubMed ID: 30588100
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic factors in stage III-IV adrenocortical carcinomas (ACC): an European Network for the Study of Adrenal Tumor (ENSAT) study.
    Libé R; Borget I; Ronchi CL; Zaggia B; Kroiss M; Kerkhofs T; Bertherat J; Volante M; Quinkler M; Chabre O; Bala M; Tabarin A; Beuschlein F; Vezzosi D; Deutschbein T; Borson-Chazot F; Hermsen I; Stell A; Fottner C; Leboulleux S; Hahner S; Mannelli M; Berruti A; Haak H; Terzolo M; Fassnacht M; Baudin E;
    Ann Oncol; 2015 Oct; 26(10):2119-25. PubMed ID: 26392430
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of Laparoscopic Adrenalectomy on Overall Survival in Patients with Nonmetastatic Adrenocortical Carcinoma.
    Huynh KT; Lee DY; Lau BJ; Flaherty DC; Lee J; Goldfarb M
    J Am Coll Surg; 2016 Sep; 223(3):485-92. PubMed ID: 27238874
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The prognosis difference between elderly and younger patients with adrenocortical carcinoma.
    He S; Huang X; Zhao P; Zhang P
    Front Genet; 2022; 13():1029155. PubMed ID: 36685908
    [No Abstract]   [Full Text] [Related]  

  • 11. External validation of a nomogram predicting mortality in patients with adrenocortical carcinoma.
    Zini L; Capitanio U; Jeldres C; Lughezzani G; Sun M; Shariat SF; Isbarn H; Arjane P; Widmer H; Perrotte P; Graefen M; Montorsi F; Karakiewicz PI
    BJU Int; 2009 Dec; 104(11):1661-7. PubMed ID: 19493261
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Laparoscopic Versus Open Adrenalectomy for Localized/Locally Advanced Primary Adrenocortical Carcinoma (ENSAT I-III) in Adults: Is Margin-Free Resection the Key Surgical Factor that Dictates Outcome? A Review of the Literature.
    Mpaili E; Moris D; Tsilimigras DI; Oikonomou D; Pawlik TM; Schizas D; Papalampros A; Felekouras E; Dimitroulis D
    J Laparoendosc Adv Surg Tech A; 2018 Apr; 28(4):408-414. PubMed ID: 29319399
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Blood Transfusion and Survival for Resected Adrenocortical Carcinoma: A Study from the United States Adrenocortical Carcinoma Group.
    Poorman CE; Postlewait LM; Ethun CG; Tran TB; Prescott JD; Pawlik TM; Wang TS; Glenn J; Hatzaras I; Shenoy R; Phay JE; Keplinger K; Fields RC; Jin LX; Weber SM; Salem A; Sicklick JK; Gad S; Yopp AC; Mansour JC; Duh QY; Seiser N; Solorzano CC; Kiernan CM; Votanopoulos KI; Levine EA; Staley CA; Poultsides GA; Maithel SK
    Am Surg; 2017 Jul; 83(7):761-768. PubMed ID: 28738949
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development and validation of nomograms for predicting survival of elderly patients with stage I small-cell lung cancer.
    Yang Y; Sun S; Wang Y; Xiong F; Xiao Y; Huang J
    Bosn J Basic Med Sci; 2021 Oct; 21(5):632-641. PubMed ID: 33577444
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identifying the Prognosis Factors and Predicting the Survival Probability in Patients with Non-Metastatic Chondrosarcoma from the SEER Database.
    Huang R; Sun Z; Zheng H; Yan P; Hu P; Yin H; Zhang J; Meng T; Huang Z
    Orthop Surg; 2019 Oct; 11(5):801-810. PubMed ID: 31663279
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic Role of Ki-67 in Adrenocortical Carcinoma After Primary Resection: A Retrospective Mono-Institutional Study.
    Zhang F; Zhang F; Liu Z; Wu K; Zhu Y; Lu Y
    Adv Ther; 2019 Oct; 36(10):2756-2768. PubMed ID: 31471770
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association between preoperative serum albumin and prognosis in patients with adrenocortical carcinoma after primary resection: a retrospective study.
    Zhang F; Liu Z; Liang J; Liu S; Wu K; Zhang F; Zhou C; Lu Y; Zhu Y; Wang X
    BMC Cancer; 2021 Aug; 21(1):961. PubMed ID: 34445989
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proposal for modification of the ENSAT staging system for adrenocortical carcinoma using tumor grade.
    Miller BS; Gauger PG; Hammer GD; Giordano TJ; Doherty GM
    Langenbecks Arch Surg; 2010 Sep; 395(7):955-61. PubMed ID: 20694732
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of SOAT1 in Adrenocortical Carcinoma and Response to Mitotane Monotherapy: An ENSAT Multicenter Study.
    Weigand I; Altieri B; Lacombe AMF; Basile V; Kircher S; Landwehr LS; Schreiner J; Zerbini MCN; Ronchi CL; Megerle F; Berruti A; Canu L; Volante M; Paiva I; Della Casa S; Sbiera S; Fassnacht M; Fragoso MCBV; Terzolo M; Kroiss M
    J Clin Endocrinol Metab; 2020 Aug; 105(8):. PubMed ID: 32449514
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic predictors of adrenocortical carcinoma: A single-center thirty-year experience.
    Pan LH; Yen CC; Huang CJ; Ng XN; Lin LY
    Front Endocrinol (Lausanne); 2023; 14():1134643. PubMed ID: 36967802
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.